Table 2 Difference in the prevalence of bothersome nocturia among all patients and elderly patients (≥ 65 years).
All (N = 299) | Elderly patients (N = 211) | ||||||
|---|---|---|---|---|---|---|---|
Non-bothersome nocturia, N(%) | Bothersome nocturia, N(%) | p-value | Non-bothersome Nocturia, N (%) | Bothersome Nocturia, N (%) | p-value | ||
Age ≥ 65 | |||||||
No | 52 (59.1%) | 36 (40.9%) | < 0.001 | ||||
Yes | 65 (30.8%) | 146 (69.2%) | |||||
Age ≥ 80 | |||||||
No | 52 (33.5%) | 103 (66.5%) | 0.151 | ||||
Yes | 13 (23.2%) | 43 (76.8%) | |||||
Sex | |||||||
Male | 52 (38.8%) | 82 (61.2%) | 0.917 | 24 (27.0%) | 65 (73.0%) | 0.302 | |
Female | 65 (39.4%) | 100 (60.6%) | 41 (33.6%) | 81 (66.4%) | |||
Obesity | |||||||
No | 53 (36.1%) | 94 (63.9%) | 0.284 | 26 (24.3%) | 81 (75.7%) | 0.038 | |
Yes | 64 (42.1%) | 88 (57.9%) | 39 (41.9%) | 54 (58.1%)) | |||
Hypertension history | |||||||
No | 36 (49.3%) | 37 (50.7%) | 0.040 | 14 (32.6%) | 29 (67.4%) | 0.780 | |
Yes | 81 (35.8%) | 145 (64.2%) | 51 (30.4%) | 117 (69.6%) | |||
Diuretic use | |||||||
No | 110 (39.0%) | 172 (61.0%) | 0.859 | 62 (31.2%) | 137 (68.8%) | 0.759 | |
Yes | 7 (41.2%) | 10 (58.8%) | 3 (25.0%) | 9 (75.0%) | |||
Diabetes mellitus history | |||||||
No | 87 (42.2%) | 119 (57.8%) | 0.102 | 47 (32.6%) | 97 (67.4%) | 0.398 | |
Yes | 30 (25.6%) | 63 (34.6%) | 18 (26.9%) | 49 (73.1%) | |||
Aortic root dilatation | |||||||
No | 104 (37.8%) | 171 (62.2%) | 0.116 | 56 (29.0%) | 137 (71.0%) | 0.106 | |
Yes | 13 (54.2%) | 11 (45.8%) | 9 (50.0%) | 9 (50.0%) | |||
Left atrial enlargement | |||||||
No | 88 (46.3%) | 102 (53.7%) | 0.001 | 46 (36.8%) | 79 (63.2%) | 0.024 | |
Yes | 29 (26.6%) | 80 (73.4%) | 19 (22.1%) | 67 (77.9%) | |||
Left ventricle hypertrophy | |||||||
No | 91 (42.5%) | 123 (57.5%) | 0.056 | 49 (35.0%) | 91 (65.0%) | 0.064 | |
Yes | 26 (30.6%) | 59 (69.4%) | 16 (22.5%) | 55 (77.5%) | |||
Concentric remodeling | |||||||
No | 74 (41.8%) | 103 (58.2%) | 0.253 | 35 (30.7%) | 79 (69.3%) | 0.972 | |
Yes | 43 (35.2%) | 79 (64.8%) | 30 (30.9%) | 67 (69.1%) | |||
Moderate-to-severe AR | |||||||
No | 97 (40.9%) | 140 (59.1%) | 0.213 | 52 (32.1%) | 110 (67.9%) | 0.459 | |
Yes | 20 (32.3%) | 42 (67.7%) | 13 (26.5%) | 36 (73.5%) | |||
Moderate-to-severe TR | |||||||
No | 74 (38.5%) | 118 (61.5%) | 0.780 | 36 (28.1%) | 92 (71.9%) | 0.295 | |
Yes | 43 (40.2%) | 64 (59.8%) | 29 (34.9%) | 54 (65.1%) | |||
Moderate-to-severe MR | |||||||
No | 89 (40.5%) | 131 (59.5%) | 0.434 | 46 (30.7%) | 104 (69.3%) | 0.945 | |
Yes | 28 (35.4%) | 51 (64.6%) | 19 (31.1%) | 42 (68.9%) | |||
Moderate-to-severe PR | |||||||
No | 91 (37.9%) | 149 (62.1%) | 0.386 | 49 (29.7%) | 116 (70.3%) | 0.509 | |
Yes | 26 (44.1%) | 33 (55.9%) | 16 (34.8%) | 30 (65.2%) | |||
LV ejection fraction | |||||||
Normal | 108 (39.7%) | 164 (60.3%) | 0.518 | 63 (32.1%) | 133 (67.9%) | 0.156 | |
Abnormal | 9 (33.3%) | 18 (66.7%) | 2 (13.3%) | 13 (86.7%) | |||
LV diastolic dysfunction | |||||||
Normal or grade I | 114 (39.4%) | 175 (60.6%) | 0.745 | 62 (30.8%) | 139 (69.2%) | 1.000 | |
Grade II to III | 3 (30.0%) | 7 (70.0%) | 3 (30.0%) | 7 (70.0%) | |||
